SCHEMBL466751

SCHEMBL466751

C=C(C)CCNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22771609 0.97
SCHEMBL14392215 0.80
SCHEMBL10158619 0.78 EPHX1 (0.46)
SCHEMBL20631939 0.78 EPHX1 (0.46)
SCHEMBL18657154 0.78 EPHX1 (0.46)
SCHEMBL24982784 0.78 EPHX1 (0.46)
SCHEMBL26551583 0.78 EPHX1 (0.46)
SCHEMBL12564481 0.78 EPHX1 (0.46)
SCHEMBL5203442 0.75
SCHEMBL21764029 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230285569-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF FRAGILE X Design Therapeutics, Inc. 2023-09-14 US disclosed
WO-2023125944-A1 COMPOUND CONTAINING HETEROCYCLIC RING 正大天晴药业集团股份有限公司 2023-07-06 WO disclosed
EP-4190402-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF, USE THEREOF, AND INTERMEDIATE THEREOF FUJIFILM Corporation (JP) 2023-06-07 EP disclosed
US-20220127256-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2022-04-28 US disclosed
WO-2021046407-A1 RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME RIGEL PHARMACEUTICALS, INC. (US) 2021-03-11 WO disclosed
EP-3213777-A1 MATERIAL NONADHESIVE TO BIOLOGICAL SUBSTANCES, CURING COMPOSITION, AND ARTIFICIAL ORGAN AND MEDICAL INSTRUMENT USING SAME FUJI-FILM Corporation (JP) 2017-09-06 EP disclosed
US-9617241-B2 Intermediate compounds and process for the preparation of efinaconazole MAPI PHARMA LTD. (IL) 2017-04-11 US disclosed
CN-106188175-A Use antibacterial aminoglycoside compounds for treating klebsiella pneumoniae infections 尔察祯有限公司 2016-12-07 CN disclosed
CN-102481307-B Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds 尔察祯有限公司 2016-08-24 CN disclosed
US-8877857-B2 Polar group-containing copolymer, rubber composition and studless tire SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2014-11-04 US disclosed
US-6991834-B1 Materials for inducing alignment of liquid crystals and liquid crystal optical elements ELSICON, INC. (US) 2006-01-31 US disclosed
EP-1155353-A4 MATERIALS FOR INDUCING ALIGNMENT OF LIQUID CRYSTALS AND LIQUID CRYSTAL OPTICAL ELEMENTS ELSICON INC (US) 2003-04-23 EP disclosed
US-6491988-B1 POLYAMIC ACID, POLYAMIDE ESTER AND POLYIMIDES; ANISOTROPICALLY ABSORBING; EXPOSING LAYER TO POLARIZED LIGHT; CROSSLINKING DIAMINES HAVING SIDE CHAINS OF C3-C22 LINEAR AND BRANCHED AND PARTIALLY FLUORINATED HYDROCARBONSCHAINS ELSICON, INC. 2002-12-10 US disclosed
EP-1155353-A1 MATERIALS FOR INDUCING ALIGNMENT OF LIQUID CRYSTALS AND LIQUID CRYSTAL OPTICAL ELEMENTS Elsicon Inc. (US) 2001-11-21 EP disclosed
US-6313348-B1 LIQUID CRYSTAL GIBBONS WAYNE M (US) 2001-11-06 US disclosed
US-6103322-A POLYAMIC ACID ELSICON INC. (US) 2000-08-15 US disclosed
WO-2000039633-A1 MATERIALS FOR INDUCING ALIGNMENT OF LIQUID CRYSTALS AND LIQUID CRYSTAL OPTICAL ELEMENTS ELSICON, INC. (US) 2000-07-06 WO disclosed
US-5723398-A CATALYST OF METAL CYCLOPENTADIENYL COMPLEX FOR POLYMERIZATION THE DOW CHEMICAL COMPANY (US) 1998-03-03 US disclosed
US-5494874-A TITANIUM COMPLEXES WITH A COCATALYST AS POLYMERIZATION CATALYSTS THE DOW CHEMICAL COMPANY (US) 1996-02-27 US disclosed
US-5374696-A Catalyzing the addition polymerization in presence of titanium metal complexes with cocatalysts THE DOW CHEMICAL COMPANY (US) 1994-12-20 US disclosed